Driver, 18, gets $3,000 ticket, 32 demerit points after speeding on Laval boulevard
A young driver received a hefty fine from Laval police after they say he was driving nearly 100 km/h over the posted speed limit.
A new study by the Centre for Addiction and Mental Health (CAMH) will attempt to harness the antidepressant power of psilocybin mushrooms, but without the psychedelic experience.
Psilocybin is the hallucinogenic chemical compound in "magic" mushrooms that generates a psychedelic high. However, clinical trials have shown psilocybin mushrooms also have antidepressant effects on people whose depression is resistant to other treatments, when combined with intensive psychotherapy.
Over a period of three years, researchers at CAMH will try to learn whether the psychedelic experience itself is necessary to treat depression in a federally-funded study that lead researcher Dr. Ishrat Husain says is the first of its kind.
"What we're trying to address with this study, which I think is a glaring question in the field, is whether the psychedelic high is required for the therapeutic benefits,” Husain told CTVNews.ca. “It's assumed that it is, but nobody's actually designed a clinical trial to answer that question."
Husain and his team will compare the outcomes of 60 adults with treatment-resistant depression. Over the course of the study, a third of the participants will receive a full dose of psilocybin plus a serotonin blocker to inhibit the drug’s psychedelic effect. Another group will be given psilocybin plus a placebo. The final group will receive a placebo, plus the serotonin blocker. All participants will also receive 12 hours of psychotherapy.
This is the second clinical psilocybin trial at CAMH, which was the Canadian site for the world’s largest clinical trial of psilocybin in mental health to date, in 2021.
If the new study shows psilocybin mushrooms have equal antidepressant effects with or without the psychedelic experience, Husain said it could be a “game changer” for people with treatment-resistant depression who aren’t candidates for a psychedelic high.
“There are certain physical and psychological contraindications to receiving potent psychoactive drugs like psilocybin,” he said. “If we're able to show that the psychedelic experience isn't entirely necessary, it could lead to a sort of new therapeutic development for the treatment of depression."
Some day, Carole Dagher might need to put her trust in a new treatment. In fact, Dagher believes it’s inevitable. After years of trying to treat her depression, she’s in a good place. But she knows it won’t last.
"I will have another dip, there's no question about it,” Dagher told CTVNews.ca. “This is just going to be my life, it's something I'm going to have to manage."
Dagher is a patient of Husain’s who suffers from treatment-resistant major depressive disorder and anxiety disorder. She first developed postpartum depression following the birth of her oldest daughter 12 years ago. Her symptoms were compounded by trauma from childhood experiences growing up in Beirut during the Lebanese Civil War In the years since her initial diagnosis, she has struggled with suicidal ideation, tried five classes of antidepressant medication, seen psychologists and tried both electroconvulsive therapy and repetitive transcranial magnetic stimulation therapy.
After those methods failed, she turned to ketamine therapy, which was approved by Health Canada to treat major depressive disorder in 2020. Ketamine is an anaesthetic that induces strong psychedelic experiences in therapeutic doses. Dagher called those experiences “horrific,” and said they were so unbearable she nearly quit the therapy before finishing her eight sessions. She stuck with it, however, and awoke one morning after her final session feeling restored.
"I opened my eyes in the morning and the sky was blue, and the birds were chirping, and I smiled for the first time in 12 years and it was a genuine smile,” she said.
She’s still doing well, with help from an antidepressant and regular therapy sessions. But she’s waiting for the day her symptoms stop responding to ketamine. When that day comes, she'll need to look for another treatment — preferably one without a high. That's why she sees so much promise in Husain’s study.
"Without the hope of innovation, I cannot survive another day. I have to believe deep down in my heart that people like Dr. Husain and hospitals like CAMH will not stop innovating. Ketamine worked now, but it might not work later,” she said. “And I'd much rather not have the psychedelic trip, and take the [psilocybin] and have it do its thing."
On the subject of access to psilocybin therapy, while Johns Hopkins University scientist David Yaden agrees being able to offer the therapy without a psychedelic experience would make it accessible to more people, he worries about patients who may want or need the full experience.
Yaden is an assistant professor at the Johns Hopkins Center for Psychedelic and Consciousness Research who has published multiple scientific articles about the use of psilocybin as a potential treatment.
“What I worry about is an unintentional side-effect of characterizing the acute subjective effects of psychedelics — the trip, so to speak — as an unwanted side effect,” he told CTVNews.ca.
"As long as participants are screened and administered psilocybin in a supportive setting, we see that these experiences can be challenging, but they're overall very positive and deeply meaningful. That's just what the data say."
Yaden also believes, based on past studies, that a dose of psilocybin without the psychedelic side-effects likely only delivers short-term neurobiological benefits. In a report released in December 2020, he and fellow Johns Hopkins researcher Roland Griffiths argued there are long term, complex changes that can only take place in the brain during a psychedelic experience.
Regardless, he said the CAMH study is asking important questions in an area of research his team would like to explore more.
“I support research like this study looking at the causal role of the acute subjective effects of psychedelics, because I think it's a very important question to examine,” he said.
"This research is important for both clinical and scientific reasons. It's great and I'm really glad it's happening. We've been trying to do this research as well. I'm very much for it."
___
If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the National Suicide Prevention Lifeline at 800-273-8255 (or 988 beginning July 16, 2022) or Canada's Talk Suicide 1-833-456-4566. The following resources are also available to support people in crisis:
Hope for Wellness Helpline (English, French, Cree, Ojibway and Inuktitut): 1-855-242-3310
Embrace Life Council hotline: 1-800-265-3333
Trans Lifeline: 1-877-330-6366
Kids Help Phone: 1-800-668-6868
A young driver received a hefty fine from Laval police after they say he was driving nearly 100 km/h over the posted speed limit.
Donald Trump was booed repeatedly while addressing Saturday night’s Libertarian Party National Convention.
Liz McGuire, the Blue Jays fan who was struck in the face with a 110 m.p.h. foul ball last week, has been pictured on a custom baseball trading card applauding her fandom to the game.
Two-time PGA Tour winner Grayson Murray died Saturday morning at age 30, one day after he withdrew from the Charles Schwab Cup Challenge at Colonial.
Cases of Lyme disease have now increased more than 1,000 per cent in a decade as the warming climate pushes the boundaries of a range of pathogens and risk factors northward.
According to some experts, there is one type of screen time that is continuously excessive, and it's having a severe effect on our children.
Decades after being punished in a residential school for speaking his own language, Sol Mamakwa will hold the powerful to account at Ontario's legislature in the very same language past governments tried to bury.
B'nai Brith Canada flagged the issue of AI-generated hate content in a recent report on antisemitism.
A 60-year-old woman saw her dreams of becoming the oldest Miss Universe contestant in history melt away in a haze of sequins and selfies Saturday at Argentina’s annual beauty pageant.
When one is extended an invitation to the Royal Garden Party in London, England, there's undoubtedly no shortage of pomp and circumstance. Barrie, Ont. natives Megan Kirk Chang and her husband Brandon experienced just that as they entered the prestigious event hosted at Buckingham Palace on Tuesday.
An unlikely celebrity emerged from social media to cheer on the Edmonton Oilers as they face the Dallas Stars tonight in Game 1 of the Western Conference Finals.
The proprietors of Regina's sole discount theatre are aware they're carrying on a significant legacy.
When Jujhar Mann said he wanted to be a pastry chef on a grade school career project, he didn't imagine that pursuing his dream would land him on a popular Netflix baking competition.
A city known for its history, ties to outer space and southern barbecue, is also home to a Winnipeg chef dishing out dozens of perogies.
A Montreal photographer captured the moment a Canada goose defended itself from a fox at the Botanical Garden.
Public libraries in Atlantic Canada are now lending a broader range of items.
Flashes of purple darting across the sky mixed with the serenading sound of songs will be noticed more with spring in full force in Manitoba.
Catching 'em all with impressive speed, a 7-year-old boy from Windsor, Ont. who only started his competitive Pokémon journey seven months ago has already levelled up to compete at a world championship level.